22 results
6-K
EX-99.1
ASND
Ascendis Pharma A/S
31 May 23
Current report (foreign)
12:01pm
of doses of IL-2 without putting the patient at unacceptable risk for severe, irreversible toxicity.” High dose interleukin-2 (Aldesleukin) – expert
6-K
EX-99.1
0u66qpwjxuv v1j
13 Jan 20
Current report (foreign)
6:12am
6-K
EX-99.1
gfptau5ccmbua wj1
26 Jun 19
Current report (foreign)
8:29am
20-F
0av 1wu7tv
26 Mar 15
Annual report (foreign)
12:00am
424B4
oomkfqv5zqcb1te9y0r
28 Jan 15
Prospectus supplement with pricing info
12:00am
F-1/A
o7n qko9d9aa
26 Jan 15
Registration statement (foreign) (amended)
12:00am
F-1/A
lnzeiq8bh4b4stv
16 Jan 15
Registration statement (foreign) (amended)
12:00am
DRS/A
bhg4w8z zvzec1y09hb
20 Oct 14
Draft registration statement (amended)
12:00am